Stone R - Search Results

1

Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms.

Steensma DP, Wermke M, Klimek VM, Greenberg PL, Font P, Komrokji RS, Yang J, Brunner AM, Carraway HE, Ades L, Al-Kali A, Alonso-Dominguez JM, Alfonso-Piérola A, Coombs CC, Deeg HJ, Flinn I, Foran JM, Garcia-Manero G, Maris MB, McMasters M, Micol JB, De Oteyza JP, Thol F, Wang ES, Watts JM, Taylor J, Stone R, Gourineni V, Marino AJ, Yao H, Destenaves B, Yuan X, Yu K, Dar S, Ohanjanian L, Kuida K, Xiao J, Scholz C, Gualberto A, Platzbecker U. Steensma DP, et al. Among authors: stone r. Leukemia. 2021 Dec;35(12):3542-3550. doi: 10.1038/s41375-021-01328-9. Epub 2021 Jun 25. Leukemia. 2021. PMID: 34172893 Free PMC article. Clinical Trial.

2

A phase I study of intermittent continuous infusion high dose cytosine arabinoside for acute leukemia.

Stone RM, Spriggs DR, Dhawan RK, Arthur KA, Mayer RJ, Kufe DW. Stone RM, et al. Leukemia. 1990 Dec;4(12):843-7. Leukemia. 1990. PMID: 2243507

3

Detection of tumor necrosis factor gene expression at a cellular level in human acute myeloid leukemias.

Wakamiya N, Stone R, Takeyama H, Spriggs D, Kufe D. Wakamiya N, et al. Among authors: stone r. Leukemia. 1989 Jan;3(1):51-6. Leukemia. 1989. PMID: 2642577

4

Therapy with recombinant human erythropoietin in patients with myelodysplastic syndromes.

Stone RM, Bernstein SH, Demetri G, Facklam DP, Arthur K, Andersen J, Aster JC, Kufe D. Stone RM, et al. Leuk Res. 1994 Oct;18(10):769-76. doi: 10.1016/0145-2126(94)90059-0. Leuk Res. 1994. PMID: 7934135 Clinical Trial.

5

All-trans retinoic acid induces monocyte growth factor receptor (c-fms) gene expression in HL-60 leukemia cells.

Hsu HC, Yang K, Kharbanda S, Clinton S, Datta R, Stone RM. Hsu HC, et al. Among authors: stone rm. Leukemia. 1993 Mar;7(3):458-62. Leukemia. 1993. PMID: 8445950

6

Bryostatin 1: differentiating agent from the depths.

Stone RM. Stone RM. Leuk Res. 1997 May;21(5):399-401. doi: 10.1016/s0145-2126(96)00123-3. Leuk Res. 1997. PMID: 9225066 Review. No abstract available.

7

Induction and postremission therapy: new agents.

Stone RM. Stone RM. Leukemia. 2003 Mar;17(3):496-8. doi: 10.1038/sj.leu.2402864. Leukemia. 2003. PMID: 12646937 No abstract available.

8

Decision-making and quality of life in older adults with acute myeloid leukemia or advanced myelodysplastic syndrome.

Sekeres MA, Stone RM, Zahrieh D, Neuberg D, Morrison V, De Angelo DJ, Galinsky I, Lee SJ. Sekeres MA, et al. Among authors: stone rm. Leukemia. 2004 Apr;18(4):809-16. doi: 10.1038/sj.leu.2403289. Leukemia. 2004. PMID: 14762444 Clinical Trial.

9

PKC 412 FLT3 inhibitor therapy in AML: results of a phase II trial.

Stone RM, De Angelo J, Galinsky I, Estey E, Klimek V, Grandin W, Lebwohl D, Yap A, Cohen P, Fox E, Neuberg D, Clark J, Gilliland DG, Griffin JD. Stone RM, et al. Ann Hematol. 2004;83 Suppl 1:S89-90. doi: 10.1007/s00277-004-0850-2. Ann Hematol. 2004. PMID: 15124689 Clinical Trial. No abstract available.

10

Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412.

Stone RM, DeAngelo DJ, Klimek V, Galinsky I, Estey E, Nimer SD, Grandin W, Lebwohl D, Wang Y, Cohen P, Fox EA, Neuberg D, Clark J, Gilliland DG, Griffin JD. Stone RM, et al. Blood. 2005 Jan 1;105(1):54-60. doi: 10.1182/blood-2004-03-0891. Epub 2004 Sep 2. Blood. 2005. PMID: 15345597 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,273 results

Search Page

Filters